Nasopharyngeal carcinoma (NPC) is a metastasis-prone malignancy closely associated
with the Epstein–Barr virus (EBV). Despite ubiquitous infection of EBV worldwide, NPC …

Background Sinonasal neoplasms, whether benign and malignant, pose a significant
challenge to clinicians and represent a model area for multidisciplinary collaboration in …

Radiotherapy is a valid treatment for nasopharyngeal carcinoma (NPC), and radioresistance
is the main cause of local NPC treatment failure. However, the underlying mechanisms and …

Background We previously conducted a prospective study to show that nasopharyngeal
cancer (NPC) screening with circulating Epstein–Barr virus (EBV) DNA analysis can improve …

The general immune landscape of nasopharyngeal carcinoma (NPC) renders
immunotherapy suitable for patients with NPC. Immune checkpoint inhibitors (ICIs) based on …

Most mature B cells can be divided into four subtypes based on the expression of the
surface markers IgD and CD27: IgD+ CD27− naïve B cells, IgD+ CD27+ unswitched memory …

Background Pembrolizumab previously demonstrated robust antitumor activity and
manageable safety in a phase Ib study of patients with heavily pretreated, programmed …

Nasopharyngeal carcinoma (NPC) is an epithelial tumor located in the nasopharynx and is
highly associated with Epstein‑Barr virus (EBV) infection. Although radiotherapy alone can …

Importance Induction chemotherapy added to concurrent chemoradiotherapy significantly
improves survival for patients with locoregionally advanced nasopharyngeal carcinoma, but …

Importance Capecitabine maintenance therapy improves survival outcomes in various
cancer types, but data are limited on the efficacy and safety of capecitabine maintenance …